Reagent Parameters for BS120/130 Chemistry Analyzers

Reac. Pri. Sec. S R1 R2 Linear Reac.Time Incuba. Substrate Antigen Linearity Range
No. Direction Unit Precision Rule
Type Wave Wave (ul) (ul) (ul) Limit From To Time Limit excess Low Up

ALT 401 Kinetic Decrease U/L 0.1 340 405 10 200 50 0.2 3 13 16 4800 / 4 1000 Two-point linear

AST 402 Kinetic Decrease U/L 0.1 340 405 10 200 50 / 3 13 16 5700 / 4 800 Two-point linear

ALP 403 Kinetic Increase U/L 0.1 405 546 4 200 50 0.2 3 13 16 26400 / 5 800 Two-point linear

γ-GT 404 Kinetic Increase U/L 0.1 405 546 20 200 50 0.2 3 13 16 19800 / 4 650 Two-point linear

TP 408 Endpoint Increase g/L 0.1 546 630 4 200 / / 0 33 / / / 2 120 Two-point linear

ALB 409 Endpoint Increase g/L 0.1 578 510 3 300 / / 0 17 / / / 3 60 Two-point linear

T-Bil-V 406 Endpoint Decrease μmol/L 0.01 450 546 7 196 49 / -1 17 16 / / 2 684 Two-point linear

D-Bil-V 407 Endpoint Decrease μmol/L 0.01 450 546 7 196 49 / -1 17 16 / / 1 430 Two-point linear

T-Bil-D 444 Endpoint Increase μmol/L 0.01 546 630 20 200 / / 0 33 / / / 1.7 600 Two-point linear

D-Bil-D 445 Endpoint Increase μmol/L 0.01 546 630 20 200 / / 0 7 / / / 1 260 Two-point linear

T-Bil-DⅡ 474 Endpoint Increase μmol/L 0.01 546 630 3 200 50 / -1 17 16 / / 1.7 600 Two-point linear

D-Bil-DⅡ 475 Endpoint Increase μmol/L 0.01 546 670 20 200 50 / -1 17 16 / / 1 260 Two-point linear

TBA 432 Kinetic Increase μmol/L 0.1 405 510 4 270 90 0.2 3 13 16 27600 / 2 180 Two-point linear

PA 431 Endpoint Increase mg/L 0.1 340 / 7 200 75 / -1 17 16 / / 10 800 Spline

ADA 436 Kinetic Increase U/L 0.01 546 / 5 180 90 0.2 10 17 16 / / 1 200 Two-point linear

5′-NT 437 Kinetic Increase U/L 0.01 546 / 10 180 90 0.2 10 17 16 / / 0.5 300 Two-point linear

UA 412 Endpoint Increase μmol/L 0.1 546 670 5 240 60 / -1 17 16 / / 20.8 1500 Two-point linear

UREA 413 Kinetic Decrease mmol/L 0.01 340 670 4.5 300 75 / 5 12 16 8000 / 0.9 40 Two-point linear

CREA-J 410 Fixed Time Increase μmol/L 0.1 510 670 18 180 180 / 2 9 16 26000 / 9 2420 Two-point linear

CREA-S 411 Endpoint Increase μmol/L 0.1 546 670 6 180 60 / -1 17 16 / / 10 7000 Two-point linear

Glu-God 415 Endpoint Increase mmol/L 0.01 510 670 3 240 60 / -1 18 16 / / 0.3 28 Two-point linear

Glu-HK 414 Endpoint Increase mmol/L 0.01 340 670 3 250 125 / -1 17 16 / / 0.6 33 Two-point linear

FUN 454 Kinetic Increase μmol/L 0.1 546 670 20 200 50 0.2 8 15 16 / / 5 1000 Two-point linear

TC 416 Endpoint Increase mmol/L 0.01 510 670 3 300 / / 0 17 / / / 0.1 20 Two-point linear

TG 417 Endpoint Increase mmol/L 0.01 510 670 3 300 / / 0 33 / / / 0.1 12.5 Two-point linear

HDL-C 421 Endpoint Increase mmol/L 0.01 578 670 3 225 75 / -1 17 16 / / 0.05 6 Two-point linear

LDL-C 420 Endpoint Increase mmol/L 0.01 578 670 3 225 75 / -1 17 16 / / 0.05 20 Two-point linear

1/2
 Reac. Pri. Sec. S R1 R2 Linear Reac.Time Incuba. Substrate Antigen Linearity Range
No. Direction Unit Precision Rule
Type Wave Wave (ul) (ul) (ul) Limit From To Time Limit excess Low Up

ApoA1 418 Endpoint Increase g/L 0.01 340 / 3 300 100 / -1 17 16 / / 0.2 2.3 Logit 5P

ApoB 419 Endpoint Increase g/L 0.01 340 / 3 300 100 / -1 17 16 / / 0.2 2.2 Logit 5P

Lp(a) 430 Endpoint Increase mg/L 0.01 340 / 18 300 30 / -1 17 16 / / 40 1000 Logit 4P

LDH 427 Kinetic Increase U/L 0.1 340 670 10 240 60 0.2 3 13 16 10700 / 4 1000 Two-point linear

α-HBDH 405 Kinetic Decrease U/L 0.1 340 546 10 240 60 0.2 3 13 16 1700 / 10 1000 Two-point linear

CK 425 Kinetic Increase U/L 0.1 340 546 5 200 50 / 10 18 16 18000 / 5 1000 Two-point linear

CK-MB 426 Kinetic Increase U/L 0.1 340 670 10 200 50 0.2 10 18 16 11000 / 5 600 Two-point linear

IgA 441 Endpoint Increase g/L 0.01 340 / 3 200 100 / -1 17 16 / / 0.2 5.6 Logit 5P

IgG 443 Endpoint Increase g/L 0.01 670 / 3 200 100 / -1 6 16 / / 0.3 35 Logit 5P

IgM 442 Endpoint Increase g/L 0.01 340 / 3 200 50 / -1 17 16 / / 0.05 4.8 Logit 5P

C3 439 Endpoint Increase g/L 0.01 340 / 3 200 100 / -1 12 16 / / 0.04 3.3 Logit 5P

C4 440 Endpoint Increase g/L 0.001 340 / 3 200 75 / -1 17 16 / / 0.015 0.8 Spline

CRP 429 Endpoint Increase mg/L 0.1 340 / 17 200 50 / -1 17 16 / / 2 150 Logit 5P

ASO 449 Fixed Time Increase IU/mL 0.1 578 / 4 200 200 / 3 16 16 / / 20 1000 Two-point linear

RF 450 Fixed Time Increase IU/mL 0.01 510 / 6 180 60 / 3 8 16 / / 4 120 Spline

Ca 422 Endpoint Increase mmol/L 0.01 630 / 3 300 / / 0 9 / / / 0.1 3.75 Two-point linear

Mg 423 Endpoint Increase mmol/L 0.01 510 630 3 300 / / 0 17 / / / 0.04 2.05 Two-point linear

P 424 Endpoint Increase mmol/L 0.01 340 450 3 300 / / 0 34 / / / 0.3 4 Two-point linear

Fe 453 Endpoint Increase μmol/L 0.1 578 670 20 250 50 / -1 17 16 / / 0.9 200 Two-point linear

α-AMY 428 Kinetic Increase U/L 0.1 405 578 5 200 50 0.2 3 10 16 22500 / 5 1500 Two-point linear

LIP 448 Kinetic Increase U/L 0.1 578 670 3 300 60 0.2 8 16 16 / / 5 250 Two-point linear

MALB 460 Endpoint Increase mg/L 0.1 340 / 16 250 40 / -1 17 16 / / 4 300 Spline

TRF 462 Endpoint Increase g/L 0.01 340 / 3 300 30 / -1 13 16 / / 0.5 4.5 Spline

ACE 464 Kinetic Decrease U/L 0.1 340 405 16 200 / 0.2 14 28 / / / 12 150 Two-point linear

β-HB 465 Endpoint Increase mmol/L 0.01 510 670 6 200 50 / -1 17 16 / / 0.03 5.5 Two-point linear

G6PD 466 Kinetic Increase U/L 1 340 405 10 200 50 0.2 3 10 16 / / 0 3000 K factor: 223930

P/N：0040-20-32369（17.0）

2/2